| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Jan 25 | CTNM Contineum Therapeutics, Inc. Class A Common Stock | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 9.79 | 300,000 | 2.94 mm | 300,000 |
| 11 Sep 24 | EYEG EyeGate Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 3.68 | 1,250 | 4.60 k | 1,250 |
| 1 Jul 24 | EYEG EyeGate Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 4.35 | 1,778 | 7.73 k | 1,778 |
| 24 May 24 | CTNM Contineum Therapeutics, Inc. Class A Common Stock | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 15.76 | 285,000 | 4.49 mm | 285,000 |
